Mogahed E, Nabil N, Ghita H, Enayet A, El-Karaksy H
Eur J Pediatr. 2025; 184(3):235.
PMID: 40063124
PMC: 11893629.
DOI: 10.1007/s00431-025-06038-3.
Al-Rawaf H, Gabr S, Iqbal A, Alghadir A
BMC Mol Cell Biol. 2024; 25(1):18.
PMID: 39030480
PMC: 11264506.
DOI: 10.1186/s12860-024-00514-8.
Belbaraka R, Benhima N, Laatabi A, El Fadli M, Essadi I
J Cancer Epidemiol. 2022; 2022:3307194.
PMID: 35265131
PMC: 8901288.
DOI: 10.1155/2022/3307194.
Ahmed H, Waly N, Abd El-Baky R, Yahia R, Hetta H, Elsayed A
PLoS One. 2021; 16(4):e0249770.
PMID: 33857212
PMC: 8049381.
DOI: 10.1371/journal.pone.0249770.
El-Tahan R, Ghoneim A, Zaghloul H
Virus Genes. 2020; 56(5):564-581.
PMID: 32572756
PMC: 7307947.
DOI: 10.1007/s11262-020-01776-y.
Generic sofosbuvir/ledipasvir for the treatment of genotype 4 chronic hepatitis C in Egyptian children (9-12 years) and adolescents.
El-Araby H, Behairy B, El-Guindi M, Adawy N, Allam A, Sira A
Hepatol Int. 2019; 13(6):706-714.
PMID: 31515739
DOI: 10.1007/s12072-019-09985-w.
Engineering Chlamydomonas reinhardtii for Expression of Functionally Active Human Interferon-α.
El-Ayouty Y, El-Manawy I, Nasih S, Hamdy E, Kebeish R
Mol Biotechnol. 2018; 61(2):134-144.
PMID: 30543053
DOI: 10.1007/s12033-018-0143-y.
Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians.
Zakaria Z, Knapp S, Hashem M, Zaghla H, Thursz M, Waked I
Immunol Res. 2018; 67(1):123-133.
PMID: 30402710
DOI: 10.1007/s12026-018-9035-2.
5' UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, Egypt.
El-Tahan R, Ghoneim A, Zaghloul H
J Adv Res. 2018; 10:39-47.
PMID: 30046475
PMC: 6057237.
DOI: 10.1016/j.jare.2018.01.004.
Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4.
Abdel-Moneim A, Aboud A, Abdel-Gabaar M, Zanaty M, Ramadan M
Hepatol Int. 2018; 12(4):348-355.
PMID: 29754329
DOI: 10.1007/s12072-018-9868-8.
Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt's hepatocellular cancer epidemic: simulation of alternatives.
Ma W, Soliman A, Anwar W, Hablas A, El Din T, Ramadan M
BMJ Glob Health. 2018; 3(2):e000572.
PMID: 29707244
PMC: 5914708.
DOI: 10.1136/bmjgh-2017-000572.
Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting.
Gayam V, Khalid M, Mandal A, Hussain M, Mukhtar O, Gill A
Gastroenterology Res. 2018; 11(2):130-137.
PMID: 29707080
PMC: 5916637.
DOI: 10.14740/gr999w.
Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.
Kouyoumjian S, Chemaitelly H, Abu-Raddad L
Sci Rep. 2018; 8(1):1661.
PMID: 29374178
PMC: 5785953.
DOI: 10.1038/s41598-017-17936-4.
Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients.
Ahmad Y, Tawfeek S, Sharaf-Eldin M, Elbatea H, Kobtan A, El-Kalla F
Hosp Pharm. 2017; 52(4):294-301.
PMID: 28515509
PMC: 5424834.
DOI: 10.1310/hpj5204-294.
Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons.
Asante-Appiah E, Curry S, McMonagle P, Ingravallo P, Chase R, Nickle D
Antimicrob Agents Chemother. 2017; 61(7).
PMID: 28416549
PMC: 5487656.
DOI: 10.1128/AAC.00363-17.
The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis.
Ghaderi-Zefrehi H, Gholami-Fesharaki M, Sharafi H, Sadeghi F, Alavian S
Hepat Mon. 2016; 16(9):e40357.
PMID: 27826320
PMC: 5097177.
DOI: 10.5812/hepatmon.40357.
Hepatitis C Virus in North Africa: An Emerging Threat.
Daw M, El-Bouzedi A, Ahmed M, Dau A, Agnan M
ScientificWorldJournal. 2016; 2016:7370524.
PMID: 27610403
PMC: 5004010.
DOI: 10.1155/2016/7370524.
Prevalence of Hepatitis C Virus Genotypes Among Patients in Countries of the Eastern Mediterranean Regional Office of WHO (EMRO): A Systematic Review and Meta-Analysis.
Sadeghi F, Salehi-Vaziri M, Almasi-Hashiani A, Gholami-Fesharaki M, Pakzad R, Alavian S
Hepat Mon. 2016; 16(4):e35558.
PMID: 27274353
PMC: 4894080.
DOI: 10.5812/hepatmon.35558.
Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.
Gabr S, Alghadir A, Allam A, Ajarem J, Al-Basher G, Abdel-Maksoud M
Clin Interv Aging. 2016; 11:523-33.
PMID: 27217734
PMC: 4862759.
DOI: 10.2147/CIA.S104599.
Hepatitis C genotype 4: The past, present, and future.
Abdel-Ghaffar T, Sira M, Naghi S
World J Hepatol. 2015; 7(28):2792-810.
PMID: 26668691
PMC: 4670951.
DOI: 10.4254/wjh.v7.i28.2792.